Applied Molecular Transport's accounts payable is $160K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2023), AMTI shows a accounts payable of $160K. That compares with $1.4M in the prior-year period — down 88.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AMTI's accounts payable is now $160K (was $1.4M) — a 88.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Applied Molecular Transport is outperforming or lagging.
Tracking AMTI's accounts payable over time shows whether Applied Molecular Transport is scaling, shrinking, or reshaping that part of the business. The current reading is $160K That compares with $1.4M in the prior-year period — down 88.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Applied Molecular Transport's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $160K) with ownership activity and broader fundamentals.
Applied Molecular Transport's accounts payable is $160K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.